BioNixus vs Kantar

    BioNixus vs Kantar — the brand-test objection

    The objection we hear most is “we already brand-test with Kantar.” That is usually true, and it is usually not the brief we are being asked to take. A brand-track or a Marketplace test answers whether the idea works. It does not answer how the SKU is facing in Panda versus a Qassim grocer.

    Keep the tracker. Add the commercial study. For the wider Kantar alternative list, see /kantar-alternative. For Kantar Health in the Gulf, see /kantar-health-alternative-gcc.

    BioNixus vs Kantar — do we switch?

    Do not switch off a Kantar brand-track that is doing its job. Add BioNixus when the objection is “we already brand-test” and the missing cut is account-level or SKU-level commercial data, traditional trade, or a category the tracker does not cover.

    • Keep Kantar forBrand health, creative testing, Marketplace consumer measurement.
    • Add BioNixus forNamed accounts, SKUs, traditional trade, and non-panel industries.
    • The objection“We have Kantar” answers the brand-test. It does not answer the commercial cut.

    BioNixus versus Kantar is usually a complement to a tracker, not a cancellation of one.

    Who each is for

    Stay with the incumbent when

    • The question is brand health, equity, or creative — and Kantar already fields the wave.
    • You need a cross-country tracker with a comparable methodology.
    • Marketplace access already answers the consumer question on the table.

    Add BioNixus when

    • The brand-test passed and the commercial team still cannot see the account.
    • Traditional trade or a named banner is the real decision unit.
    • Someone said “we have Kantar” as a reason not to measure facings, offtake, or a non-FMCG category.

    Alternatives compared

    Include real options. Being listed here is not an attack on the incumbent — it is a shortlist for buyers who typed this query.

    FirmBest forCoverageModel
    BioNixusCommercial primary research after (or beside) a brand-test — accounts, SKUs, traditional trade48 countries — MENA, Europe, Americas, AsiaProject- and country-based. No tracker minimum.
    KantarBrand tracking, creative testing, Marketplace consumer panelsGlobal network; GCC via Dubai hubSyndicated trackers plus custom quant
    NielsenIQModern-trade retail measurement for FMCG and OTCGlobal syndicated coverageSyndicated subscription
    IpsosCustom U&A and brand studies at network scaleRiyadh, Jeddah, Dubai and global networkProject-based at large-agency scale
    Oracle Life Sciences (ex Kantar Health)Legacy Kantar Health pharma capability now under OracleGlobal life-sciences stackEnterprise healthcare data and research
    EuromonitorDesk category sizingPassport reportsReport and database subscription

    You do not have to switch off

    The usual model is the subscription you already buy, plus a custom study for the accounts, cities, and SKUs the feed cannot produce. BioNixus complements Nielsen, Kantar, GfK, IMS Health, and IQVIA. It does not replace them.

    Proposal ready within 48 hours of a brief. Email admin@bionixus.com or request a proposal below.

    Frequently asked questions

    We already brand-test with Kantar. Why would we hire BioNixus?

    Because a brand-test and an account-level commercial study answer different questions. The tracker can say the idea works. It cannot say how the SKU is performing in a named banner or in traditional trade.

    Is BioNixus a Kantar competitor on brand-track?

    Not as a replacement tracker. We are the commercial complement when the tracker is already bought and the gap is accounts, SKUs, or a category Kantar does not audit.

    What about Kantar Health?

    The pharma-focused Kantar Health business was sold and now sits with Oracle Life Sciences. For Gulf healthcare primary work, see our Kantar Health alternative in the GCC. This page is commercial brand-test versus account data.

    Can procurement keep both vendors?

    Yes. That is the usual model. Do not force a single-vendor RFP onto a tracker and a primary commercial study.

    How fast can BioNixus scope the commercial cut?

    A proposal is ready within 48 hours of a brief. Pricing is by project and country.

    Related resources

    Kantar alternative

    Wider alternatives list — this page is the brand-test objection.

    Kantar Health alternative GCC

    Healthcare-specific Gulf page.

    BioNixus vs Nielsen

    When the subscription is a retail panel, not a brand-track.

    Account-level data

    What the tracker does not show.

    Market research firms KSA

    Country ranking — includes Kantar.

    Pricing bands

    Project- and country-based ranges.

    The brand-test passed. The account is still dark.

    Account-level or SKU-level primary research beside the Kantar tracker you already buy. Proposal ready within 48 hours of a brief.

    Planning research in Saudi Arabia?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Request a proposal